EUVIMEDEUVIMED entdecken
Crossref

Investigations of Limeum Indicum Plant for Diabetes Mellitus and Alzheimer's Disease Dual Therapy: Phytochemical, GC‐MS Chemical Profiling, Enzyme Inhibition, Molecular Docking and In‐Vivo Studies

Tahira Shamim, Hafiz Muhammad Asif, Syeda Abida Ejaz iD, Zahid Hussain, Tanveer A Wani, Laila Sumreen, Muhammad Abdullah, Zubair Ahmed, Jamshed Iqbal, Song Ja Kim, Muhammad Kamal Shah

Chemistry & Biodiversity · 2024

DOI: 10.1002/cbdv.202301858 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Tahira Shamim und 10 weiteren Autor:innen. Beteiligte Einrichtung: University College of Conventional Medicine, Faculty of Medicine & Allied Health Sciences, The Islamia University of Bahawalpur, 63100, Bahawalpur, P…. Hauptthemen laut MEDLINE: Alzheimer Disease, Molecular Docking Simulation, Phytochemicals, Gas Chromatography-Mass Spectrometry. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: King Saud University Researchers, King Saud University, Riyadh, Saudi Arabia, National Research Foundation of Korea (NRF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Limeum indicum has been widely utilized in traditional medicine but no experimental work has been done on this herb. The primary objective of this study was to conduct a phytochemical analysis and assess the multifunctional capabilities of aforementioned plant in dual therapy for Alzheimer′s disease (AD) and Type 2 diabetes (T2D). The phytochemical screening of ethanol, methanol extract, and their derived fractions of Limeum indicum was conducted using GC‐MS, HPLC, UV‐analysis and FTIR. The antioxidant capacity was evaluated by DPPH method. The inhibitory potential of the extracts/fractions against α‐, β‐glucosidase acetylcholinesterase (AChE), butyrylcholinesterase (BChE) and monoaminine oxidases (MAO‐A & B) was evaluated. Results revealed that acetonitrile fraction has highest inhibitory potential against α‐glucosidase (IC 50 =68.47±0.05 μg/mL), methanol extract against β‐glucosidase (IC 50 =91.12±0.07 μg/mL), ethyl acetate fraction against AChE (IC 50 =59.0±0.02 μg/mL), ethanol extract against BChE (28.41±0.01 μg/mL), n‐hexane fraction against MAO‐A (IC 50 =150.5±0.31 μg/mL) and methanol extract for MAO‐B (IC 50 =75.95±0.13 μg/mL). The docking analysis of extracts\fractions suggested the best binding scores within the active pocket of the respective enzymes. During the in‐vivo investigation, ethanol extract produced hypoglycemic effect (134.52±2.79 and 119.38±1.40 mg/dl) after 21 days treatment at dose level of 250 and 500 mg/Kg. Histopathological findings further supported the in‐vivo studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMolecular Docking SimulationPhytochemicalsGas Chromatography-Mass SpectrometryPlant ExtractsAcetylcholinesteraseButyrylcholinesteraseHypoglycemic AgentsMonoamine OxidaseAnimalsDiabetes Mellitus, Type 2Diabetes Mellitus, ExperimentalCholinesterase InhibitorsAntioxidantsMalealpha-GlucosidasesRatsbeta-GlucosidaseHumans

Stichwörter der Autor:innen

Alzheimer′s Disease (AD)Limeum indicumMedicinal plantsType 2 Diabetes Mellitus (T2D)

Substanzen

PhytochemicalsPlant ExtractsAcetylcholinesteraseButyrylcholinesteraseHypoglycemic AgentsMonoamine OxidaseCholinesterase InhibitorsAntioxidantsalpha-Glucosidasesbeta-Glucosidase

Autor:innen und Institutionen

  • University College of Conventional Medicine, Faculty of Medicine & Allied Health Sciences, The Islamia University of Bahawalpur, 63100, Bahawalpur, Pakistan.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The Islamia University of Bahawalpur, 63100, Bahawalpur, Pakistan.
  • Department of Chemistry, COMSATS University Islamabad, Abbottabad Campus, 22060, Abbottabad, Pakistan.
  • Center for Advance Drug Research, COMSATS University Islamabad, Abbottabad Campus, 22060, Abbottabad, Pakistan.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O.Box 2452, 11451, Riyadh, Saudi Arabia.
  • Cholistan Institute of Desert Studies, The Islamia University of Bahawalpur, 63100, Bahawalpur, Pakistan.

ORCID-Profile: Syeda Abida Ejaz

Förderung

  • King Saud University Researchers
  • King Saud University, Riyadh, Saudi Arabia
  • National Research Foundation of Korea (NRF)
  • Korean Government (MEST)

Zitieren

APA

Shamim, T., Asif, H. M., Abida Ejaz, S., Hussain, Z., Wani, T. A., Sumreen, L., Abdullah, M., Ahmed, Z., Iqbal, J., Kim, S. J., & Shah, M. K. (2024). Investigations of Limeum Indicum Plant for Diabetes Mellitus and Alzheimer's Disease Dual Therapy: Phytochemical, GC‐MS Chemical Profiling, Enzyme Inhibition, Molecular Docking and In‐Vivo Studies. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202301858

Vancouver

Shamim T, Asif HM, Abida Ejaz S, Hussain Z, Wani TA, Sumreen L, et al. Investigations of Limeum Indicum Plant for Diabetes Mellitus and Alzheimer's Disease Dual Therapy: Phytochemical, GC‐MS Chemical Profiling, Enzyme Inhibition, Molecular Docking and In‐Vivo Studies. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202301858

BibTeX
@article{Shamim2024,
  author = {Shamim, Tahira and Asif, Hafiz Muhammad and Abida Ejaz, Syeda and Hussain, Zahid and Wani, Tanveer A and Sumreen, Laila and Abdullah, Muhammad and Ahmed, Zubair and Iqbal, Jamshed and Kim, Song Ja and Shah, Muhammad Kamal},
  title = {Investigations of Limeum Indicum Plant for Diabetes Mellitus and Alzheimer's Disease Dual Therapy: Phytochemical, GC‐MS Chemical Profiling, Enzyme Inhibition, Molecular Docking and In‐Vivo Studies},
  journal = {Chemistry & Biodiversity},
  year = {2024},
  doi = {10.1002/cbdv.202301858}
}
Kostenlos starten →